Bio-technology General Enters Strategic Alliance

Bio-Technology General Corp. has announced a major, wide-ranging alliance with Al-Kindi Pharmaceutical Industries, a Jordanian company based in Amman, for the distribution of BTG’s pharmaceutical products throughout the Arab world. Under the terms of the agreement, Al-Kindi has exclusive rights to market BTG’s Bio-Hep-B recombinant hepatitis-B vaccine in Jordan, and BTG’s Bio-Tropin recombinant human growth Read more about Bio-technology General Enters Strategic Alliance[…]

Bio-Technology General Signs Deal For BioTechnology

Bio-Technology General Corp. has entered into an exclusive agreement with DePuy Orthopaedics Inc. (DePuy), for BioHy, BTG’s proprietary high molecular weight sodium hyaluronate product, for the treatment of pain associated with osteoarthritis of the knee. The agreement grants DePuy exclusive marketing rights to BioHy in all countries worldwide except Japan and Israel. Clinical efforts, where Read more about Bio-Technology General Signs Deal For BioTechnology[…]